Cocaine esterase

Last updated
Identifiers
EC no. 3.1.1.84
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Search
PMC articles
PubMed articles
NCBI proteins

The chloride cocaine esterase (EC 3.1.1.84, CocE, hCE2, hCE-2, human carboxylesterase 2; systematic name cocaine benzoylhydrolase) [1] [2] [3] [4] [5] catalyses the reaction

cocaine + H2O ecgonine methyl ester + benzoate

Rhodococcus sp. strain MB1 and Pseudomonas maltophilia strain MB11L can utilize cocaine as sole source of carbon and energy.

The theoretical molecular mass is 62,128 Da. [6] This enzyme and redesigned versions of it have been studied as a potential treatment for cocaine addiction in humans. [7]

TNX-1300 (T172R/G173Q double-mutant cocaine esterase 200 mg, i.v. solution) [8] is being developed under an Investigational New Drug application (IND) for the treatment of cocaine intoxication. [9] TNX-1300 (formerly known as RBP-8000) is a recombinant protein enzyme produced through rDNA technology in a non-disease-producing strain of E. coli bacteria. Cocaine Esterase (CocE) was identified in bacteria (Rhodococcus) that use cocaine as its sole source of carbon and nitrogen and that grow in soil surrounding coca plants. [10]  The gene encoding CocE was identified and the protein was extensively characterized. [1] [4] [10] [11] CoCE catalyzes the breakdown of cocaine into metabolite ecgonine methyl ester and benzoic acid. Wild-type CocE is unstable at body temperature, so targeted mutations were introduced in the CocE gene and resulted in the T172R/G173Q Double-Mutant CocE, which is active for approximately 6 hours at body temperature. [1]  In a Phase 2 study, TNX-1300 at 100 mg or 200 mg i.v. doses was well tolerated and interrupted cocaine effects after cocaine 50 mg i.v. challenge. [9]

The enzyme is important in bioremediation, levels of cocaine in European ocean water were cited at 20 ng/L, similar levels in which swollen muscles, and in some cases broken muscle fibers of eels were reported in a controlled study. [12]

Related Research Articles

<span class="mw-page-title-main">Filamentation</span> Type of bacteria growth

Filamentation is the anomalous growth of certain bacteria, such as Escherichia coli, in which cells continue to elongate but do not divide. The cells that result from elongation without division have multiple chromosomal copies.

<i>Rhodococcus fascians</i> Species of bacterium

Rhodococcus fascians is a Gram positive bacterial phytopathogen that causes leafy gall disease. R. fascians is the only phytopathogenic member of the genus Rhodococcus; its host range includes both dicotyledonous and monocotyledonous hosts. Because it commonly afflicts tobacco (Nicotiana) plants, it is an agriculturally significant pathogen.

<i>Comamonas testosteroni</i> Species of bacterium

Comamonas testosteroni is a Gram-negative environmental bacterium capable of utilizing testosterone as a carbon source, and degrading other sterols such as ergosterol and estrogens. Strain I2gfp has been used in bioaugmentation trials, in attempts to treat the industrial byproduct 3-chloroaniline. It was first classified as a human pathogen in 1987 according to the National Library of Medicine. A number of strains of Comamonas, including C. testosteroni, have been shown to consume terephthalic acid, one of the components of PET plastic, as a sole carbon source.

<span class="mw-page-title-main">Atrazine chlorohydrolase</span> Enzyme

Atrazine Chlorohydrolase (AtzA) is an enzyme (E.C.3.8.1.8), which catalyzes the conversion of atrazine to hydroxyatrazine. Bacterial degradation determines the environmental impact and efficacy of an herbicide or pesticide. Initially, most pesticides are highly effective and show minimal bacterial degradation; however, bacteria can rapidly evolve and gain the ability to metabolize potential nutrients in the environment. Despite a remarkable structural similarity, degradation of atrazine by bacteria capable of melamine degradation was rare; however, since its introduction as a pesticide in the United States, bacteria capable of atrazine degradation have evolved. Currently, Pseudomonas sp. strain ADP seems to be the optimal bacterial strain for atrazine degradations, which appears to be the sole nitrogen source for the bacteria.

<i>Roseobacter</i> Genus of bacteria

In taxonomy, Roseobacter is a genus of the Rhodobacteraceae. The Roseobacter clade falls within the {alpha}-3 subclass of the class Alphaproteobacteria. The first strain descriptions appeared in 1991 which described members Roseobacterlitoralis and Roseobacterdenitrificans, both pink-pigmented bacteriochlorophyll a-producing strains isolated from marine algae. The role members of the Roseobacter lineage play in marine biogeochemical cycles and climate change cannot be overestimated. Roseobacters make up 25% of coastal marine bacteria and members of this lineage process a significant portion of the total carbon in the marine environment. Roseobacter clade plays an important role in global carbon and sulphur cycles. It can also degrade aromatic compounds, uptake trace metal, and form symbiotic relationship. In term of its application, Roseobacter clade produces bioactive compounds, has been used widely in aquaculture and quorum sensing.

<i>Rhodococcus equi</i> Species of bacterium

Rhodococcus equi is a Gram-positive coccobacillus bacterium. The organism is commonly found in dry and dusty soil and can be important for diseases of domesticated animals. The frequency of infection can reach near 60%. R. equi is an important pathogen causing pneumonia in foals. Since 2008, R. equi has been known to infect wild boar and domestic pigs. R. equi can infect humans. At-risk groups are immunocompromised people, such as HIV-AIDS patients or transplant recipients. Rhodococcus infection in these patients resemble clinical and pathological signs of pulmonary tuberculosis. It is facultative intracellular.

<span class="mw-page-title-main">Vanillic acid</span> Chemical compound

Vanillic acid is a dihydroxybenzoic acid derivative used as a flavoring agent. It is an oxidized form of vanillin. It is also an intermediate in the production of vanillin from ferulic acid.

<span class="mw-page-title-main">Aryldialkylphosphatase</span>

Aryldialkylphosphatase is a metalloenzyme that hydrolyzes the triester linkage found in organophosphate insecticides:

In enzymology, a long-chain-alcohol O-fatty-acyltransferase is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Class II bacteriocin</span>

Class II bacteriocins are a class of small peptides that inhibit the growth of various bacteria.

A killer yeast is a yeast, such as Saccharomyces cerevisiae, which is able to secrete one of a number of toxic proteins which are lethal to susceptible cells. These "killer toxins" are polypeptides that kill sensitive cells of the same or related species, often functioning by creating pores in target cell membranes. These yeast cells are immune to the toxic effects of the protein due to an intrinsic immunity. Killer yeast strains can be a problem in commercial processing because they can kill desirable strains. The killer yeast system was first described in 1963. Study of killer toxins helped to better understand the secretion pathway of yeast, which is similar to those of more complex eukaryotes. It also can be used in treatment of some diseases, mainly those caused by fungi.

<i>Raoultella planticola</i> Species of bacterium

Raoultella planticola is a Gram-negative bacterium of the genus Raoultella. R. planticola is quite similar in appearance to Klebsiella pneumoniae and must be identified based on growth habits or DNA analysis. A number of strains have been identified.

<span class="mw-page-title-main">2,4-Diacetylphloroglucinol</span> Chemical compound

2,4-Diacetylphloroglucinol or Phl is a natural phenol found in several bacteria:

<i>Candidatus</i> Accumulibacter phosphatis Species of bacterium

Candidatus Accumulibacter phosphatis (CAP) is an unclassified type of Betaproteobacteria that is a common bacterial community member of sewage treatment and wastewater treatment plants performing enhanced biological phosphorus removal (EBPR) and is a polyphosphate-accumulating organism. The role of CAP in EBPR was elucidated using culture-independent approaches such as 16S rRNA clone banks that showed the Betaproteobacteria dominated lab-scale EBPR reactors. Further work using clone banks and fluorescence in situ hybridization identified a group of bacteria, closely related to Rhodocyclus as the dominant member of lab-scale communities.

The enzyme pyrethroid hydrolase (EC 3.1.1.88, pyrethroid-hydrolyzing carboxylesterase, pyrethroid-hydrolysing esterase, pyrethroid-hydrolyzing esterase, pyrethroid-selective esterase, pyrethroid-cleaving enzyme, permethrinase, PytH, EstP; systematic name pyrethroid-ester hydrolase) catalyses the reaction

Desulfovibrio oxyclinae is a bacterium. It is sulfate-reducing, and was first isolated from the upper 3mm layer of a hypersaline cyanobacterial mat in Sinai.

Desulfovibrio gracilis is a moderately halophilic bacteria. It is sulfate-reducing, mesophilic and motile. Its type strain is SRL6146T.

Thermotoga naphthophila is a hyperthermophilic, anaerobic, non-spore-forming, rod-shaped fermentative heterotroph, with type strain RKU-10T.

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

Cytochrome P450, family 105, also known as CYP105, is a cytochrome P450 monooxygenase family in bacteria, predominantly found in the phylum Actinomycetota and the order Actinomycetales. The first three genes and subfamilies identified in this family is the herbicide-inducible P-450SU1 and P-450SU2 from Streptomyces griseolus and choP from Streptomyces sp's cholesterol oxidase promoter region.

References

  1. 1 2 3 Gao D, Narasimhan DL, Macdonald J, Brim R, Ko MC, Landry DW, Woods JH, Sunahara RK, Zhan CG (February 2009). "Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity". Molecular Pharmacology. 75 (2): 318–23. doi:10.1124/mol.108.049486. PMC   2684895 . PMID   18987161.
  2. Bresler MM, Rosser SJ, Basran A, Bruce NC (March 2000). "Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1". Applied and Environmental Microbiology. 66 (3): 904–8. Bibcode:2000ApEnM..66..904B. doi:10.1128/aem.66.3.904-908.2000. PMC   91920 . PMID   10698749.
  3. Britt AJ, Bruce NC, Lowe CR (April 1992). "Identification of a cocaine esterase in a strain of Pseudomonas maltophilia". Journal of Bacteriology. 174 (7): 2087–94. doi:10.1128/jb.174.7.2087-2094.1992. PMC   205824 . PMID   1551831.
  4. 1 2 Larsen NA, Turner JM, Stevens J, Rosser SJ, Basran A, Lerner RA, Bruce NC, Wilson IA (January 2002). "Crystal structure of a bacterial cocaine esterase". Nature Structural Biology. 9 (1): 17–21. doi:10.1038/nsb742. PMID   11742345. S2CID   847034.
  5. Pindel EV, Kedishvili NY, Abraham TL, Brzezinski MR, Zhang J, Dean RA, Bosron WF (June 1997). "Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin". The Journal of Biological Chemistry. 272 (23): 14769–75. doi: 10.1074/jbc.272.23.14769 . PMID   9169443.
  6. Bresler, Matthew M.; Rosser, Susan J.; Basran, Amrik; Bruce, Neil C. (March 2000). "Gene Cloning and Nucleotide Sequencing and Properties of a Cocaine Esterase from Rhodococcus sp. Strain MB1". Applied and Environmental Microbiology. 66 (3): 904–908. Bibcode:2000ApEnM..66..904B. doi:10.1128/AEM.66.3.904-908.2000. ISSN   0099-2240. PMC   91920 . PMID   10698749.
  7. Narasimhan D, Woods JH, Sunahara RK (February 2012). "Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction". Future Medicinal Chemistry . 4 (2): 137–50. doi:10.4155/fmc.11.194. PMC   3290992 . PMID   22300094.
  8. "Tonix boosts pipeline with Columbia University-developed cocaine intoxication drug". FierceBiotech. Retrieved 2019-05-28.
  9. 1 2 Nasser, Azmi F.; Fudala, Paul J.; Zheng, Bo; Liu, Yongzhen; Heidbreder, Christian (2014-10-02). "A Randomized, Double-Blind, Placebo-Controlled Trial of RBP-8000 in Cocaine Abusers: Pharmacokinetic Profile of RBP-8000 and Cocaine and Effects of RBP-8000 on Cocaine-Induced Physiological Effects". Journal of Addictive Diseases. 33 (4): 289–302. doi:10.1080/10550887.2014.969603. ISSN   1055-0887. PMID   25299069. S2CID   8417112.
  10. 1 2 Bresler, M. M.; Rosser, S. J.; Basran, A.; Bruce, N. C. (2000). "Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1". Applied and Environmental Microbiology. 66 (3): 904–908. Bibcode:2000ApEnM..66..904B. doi:10.1128/aem.66.3.904-908.2000. ISSN   0099-2240. PMC   91920 . PMID   10698749.
  11. Turner, James M.; Larsen, Nicholas A.; Basran, Amrik; Barbas, Carlos F.; Bruce, Neil C.; Wilson, Ian A.; Lerner, Richard A. (2002-10-15). "Biochemical characterization and structural analysis of a highly proficient cocaine esterase". Biochemistry. 41 (41): 12297–12307. doi:10.1021/bi026131p. ISSN   0006-2960. PMID   12369817.
  12. "European eels found to suffer muscle damage due to cocaine in the water".